ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,583.50
-6.50 (-0.41%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -6.50 -0.41% 1,583.50 1,582.50 1,583.00 1,595.50 1,580.00 1,593.00 5,931,081 16:35:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.22 65.15B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,590p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £65.15 billion. Gsk has a price to earnings ratio (PE ratio) of 13.22.

Gsk Share Discussion Threads

Showing 30651 to 30675 of 33100 messages
Chat Pages: Latest  1228  1227  1226  1225  1224  1223  1222  1221  1220  1219  1218  1217  Older
DateSubjectAuthorDiscuss
12/8/2022
08:25
Did dame Emma give Jope a ring yet, or too busy doing high teas, rowing regattas and polio parties?
purplepelmets
12/8/2022
08:23
UnastubsI thought bond prices would fall as inflation rises?
ch1ck
12/8/2022
08:22
The weakest of rallys fading fast.
spoole5
12/8/2022
08:22
Google figures updated daily.
PE ratio 11.02 (about the same as many banks)
Dividend Yield 6.58%

netcurtains
12/8/2022
08:21
If the drug was not sold in the US how it there a case to answer?CONFUSED
ch1ck
12/8/2022
08:19
yep absolutely
wall street trader
12/8/2022
08:19
Agree this is time to top up as issue is not a problem. Looking good price to fill ya boots.
halfpenny
12/8/2022
08:19
#30460

Completion of GSK Share Consolidation
"expected dividend for 2023 converts to 56.25p per new ordinary share."

.5625/14.60 = 3.85% so for £20k means £770pa not £1000 pa. £11.25 would be the share price where 56.25p earnt me £1000 a year.

I can get 3.2% on a one year fixed bond right now and that's only going to improve going forward. GSK not the place for income right now, capital appreciation also in doubt. therefore i wait.

unastubbs
12/8/2022
08:12
Leave it in Compounding in a few years you will be getting a lot more than £1000 a year.No brainier
tfergi
12/8/2022
08:09
Let's be honest here this isn't going out of business or dropping the dividend Invest £20K at this level and you will get over a thousand quid a year for the rest of your life - a no brainier for me
wall street trader
12/8/2022
08:04
Grabbed some more this morning to help with the average.
Still need 1585 to be back to square one but more confident today than yesterday.

tuftymatt
12/8/2022
07:46
Has been for the last two years just closer to the first cases. It will rumble on for years too of course
daneswooddynamo
12/8/2022
07:46
sure. haha. tbh looking to invest and hold. hence trying to get the best price possible. think there could be an opportunity ahead which better reflects all the known risks.
unastubbs
12/8/2022
07:44
Nothing new in the statement just as there was nothing new over the past few days. All the info is out there
spoole5
12/8/2022
07:42
unastubbs: Sounds like you should have bought some yesterday and now you're having a bit of a temper fit.
netcurtains
12/8/2022
07:34
obviously the ADR improvement last night gives some indication of where this is going today, but to my mind the statement changes nothing. the fact of the litigation exists, with potential to blow up in every country where zantac has been sold. until this is dealt with entirely there will be a huge cloud of uncertainty and despond over GSK (and HLN & SAN). i personally am happy to be on the sidelines for now, would consider an entry point south of £12.
unastubbs
12/8/2022
07:31
How much are we expecting it to rise on open?
netcurtains
12/8/2022
07:26
A well explained statement that makes it clear what the company thinks of this and will do about it. Bound to recover today on the back of that but by how much remains to be seen.
tuftymatt
12/8/2022
07:20
NIce to see GSK reference the same study I highlighted yesterday (plus others). On an individual basis it will be almost impossible to prove anyones illness was directly caused by Zantac. Litigation is a minefield though.
dr biotech
12/8/2022
07:11
Am reassured by statement but will hold back unless as stated previously dips further over coming weeks

Mind if up 30% as some have predicted will be happy to take some profit

For now just happy to have got one right

jubberjim
12/8/2022
07:06
Well that will,so the trick expect this to be up 10% today and get nearer 30% in the next couple of months
wall street trader
12/8/2022
07:01
Statement out
spoole5
12/8/2022
06:58
FT Alphaville's take, published during trading hours yesterday:
zho
12/8/2022
06:33
Let's see what today brings.Sanofi's share price chart followed GSK'S very closely until they recovered in the afternoon to be only just over 3% down.GSK's share price flattened around the 1400p mark mostly.
redbaron10
12/8/2022
00:23
Relentless selling by hedge funds who would not dump stock like this and in this quantity without inside knowledge and good reason. First trial just days away. PI's do not move share prices...
justiceforthemany
Chat Pages: Latest  1228  1227  1226  1225  1224  1223  1222  1221  1220  1219  1218  1217  Older

Your Recent History

Delayed Upgrade Clock